Back in October of 2017, UFC heavyweight Azunna Anyanwu was flagged by the United States Anti-Doping Agency (USADA) for a failed drug test. Now the fighter is facing a year long suspension from competition for the recent drug test failure.
In an out-of-competition drug test from Oct. 18, 2017, Anyanwu tested positive for the substance furosemide.
Here is the official report from USADA:
USADA announced today that UFC athlete, Azunna Anyanwu, of Bensalem, Pa., has tested positive for a prohibited substance and accepted the standard one-year sanction for his anti-doping policy violation.
Anyanwu, 36, tested positive for furosemide following an out-of-competition urine test conducted on October 18, 2017. Furosemide is a Specified Substance in the class of Diuretics and Masking Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Anyanwu’s one-year period of ineligibility began on October 18, 2017, the date his positive sample was collected.
Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing in order to receive credit for time completed under their sanction.
